Adulterated Ranitidine, and Before that, Valsartan, Irbesartan and Losartan Another case of drug adulteration has just been made public. Per the New York Times, Sept 13, 2019, The Food and Drug Administration said on Friday that it had detected low levels of a cancer-causing contaminant in samples of heartburn medicines containing the drug commonly known as Zantac. Zantac, the brand-name
from Health Care Renewal https://ift.tt/2ZZwaDP
via IFTTT
Langganan:
Posting Komentar (Atom)
0 Response to "Broken Trust: the Adulteration of Ranitidine Revealed"
Posting Komentar